StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MNPR

Monopar Therapeutics Inc.

MNPR Nasdaq Pharmaceutical Preparations EDGAR ↗
$111.64
-3.02 -2.63%

Key statistics

from XBRL data in SEC filings
Market cap
$748M
Revenue (TTM)
$0.00
Net income (TTM)
-$15.0M
EPS (TTM)
$-1.93
P/E ratio
Dividend yield
Free cash flow
Cash
$52.5M
Total assets
$138M
Gross margin
52-week range
$29.18 – $116.69

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 22, 2026 8-K Regulation FD disclosure Jun 30, 2026 8-K Regulation FD disclosure Jun 26, 2026 8-K Shareholder vote results Jun 23, 2026 8-K Regulation FD disclosure May 29, 2026 8-K Regulation FD disclosure May 19, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Regulation FD disclosure Apr 20, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 1, 2026 8-K Results of operations (earnings release) Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Regulation FD disclosure Mar 2, 2026 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Regulation FD disclosure Nov 10, 2025 8-K Entered a material agreement; Regulation FD disclosure Sep 24, 2025 8-K Regulation FD disclosure Sep 15, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Shareholder vote results Jun 23, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Regulation FD disclosure May 7, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Director or officer change Mar 3, 2025 8-K Director or officer change Feb 24, 2025 8-K Entered a material agreement; Unregistered sale of equity Dec 23, 2024 8-K Regulation FD disclosure Dec 6, 2024 8-K Results of operations (earnings release) Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Entered a material agreement; Regulation FD disclosure Oct 30, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events Oct 24, 2024 8-K Regulation FD disclosure Oct 22, 2024 8-K Regulation FD disclosure Oct 15, 2024 8-K Regulation FD disclosure Oct 7, 2024 8-K Regulation FD disclosure Sep 12, 2024 8-K Regulation FD disclosure Aug 27, 2024 8-K Regulation FD disclosure Aug 21, 2024